Wockhardt Shares Jump 3% On UK Health Regulator Approval

New Delhi: Shares of drug firm Wockhardt surged over three per cent on bourses in early trade today after the UK health regulator confirmed that its manufacturing facility at Chikalthana in Maharashtra complies with good manufacturing practices (GMP).

On BSE, the scrip opened at Rs 699 and jumped 3.24 per cent to an early high of Rs 704. At 1147 hours, it was trading at Rs 689.50, up 1.11 per cent.

On NSE, the stock opened at Rs 698.90 and rose 3.07 per cent to an early high of Rs 703.75. At 1147 hours, it was trading 0.86 per cent up at Rs 688.60.

In a BSE filing yesterday, Wockhardt said, "UK MHRA (UK Medicines and Healthcare products Regulatory Agency) has since confirmed that general compliance with the principles and guidelines of good manufacturing practice of the company's manufacturing unit at L-1, Chikalthana, Aurangabad."

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)